| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |